SCHEMBL17324397

SCHEMBL17324397

COC(=O)C[PH](C)(c1ccccc1)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.44
TSHR P16473 1/20 0.41
ALDH1A1 P00352 3/20 0.40
LMNA P02545 3/20 0.40
KDM4E B2RXH2 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
AKT1 P31749 1/20 0.39
HSD17B10 Q99714 2/20 0.38
HPGD P15428 1/20 0.38
ALOX15 P16050 1/20 0.38
MAPK1 P28482 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
CA12 O43570 1/20 0.37
CA7 P43166 1/20 0.37
CA9 Q16790 1/20 0.37
CA14 Q9ULX7 1/20 0.37
ESRRB O95718 1/20 0.37
KMT2A Q03164 2/20 0.37
KCNN4 O15554 1/20 0.37
MAPT P10636 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23731932 0.82 POLB (0.46) POLBTSHRALDH1A1LMNAKDM4E
SCHEMBL759613 0.82 POLB (0.46) POLBTSHRALDH1A1LMNAKDM4E
Bromide SCHEMBL29024015 0.81 POLB (0.44) POLBTSHRALDH1A1LMNAKDM4E
SCHEMBL27709660 0.76 ALDH1A1 (0.46) POLBTSHRALDH1A1LMNAKDM4E
SCHEMBL19120744 0.73 OPRM1 (0.41) SMN1; SMN2MAPK1CA12CA9KMT2A
SCHEMBL9524467 0.72 ALDH1A1 (0.50) POLBTSHRALDH1A1LMNAKDM4E
SCHEMBL12231875 0.72 SMN1; SMN2 (0.41) POLBSMN1; SMN2HSD17B10HPGDMAPK1
SCHEMBL11095550 0.71 TSHR (0.42) POLBTSHRALDH1A1LMNAKDM4E
SCHEMBL9329405 0.70 POLB (0.46) POLBTSHRALDH1A1LMNAKDM4E
SCHEMBL1629392 0.69 ALDH1A1 (0.44) POLBTSHRALDH1A1LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9315531-B2 Titanocene-gold derivatives comprising thiolato ligands RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK (US) 2016-04-19 US disclosed
US-20150353591-A1 TITANOCENE-GOLD DERIVATIVES COMPRISING THIOLATO LIGANDS UNIVERSITY OF HAWAII 2015-12-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150353591-A1 TITANOCENE-GOLD DERIVATIVES COMPRISING THIOLATO LIGANDS MUC1, TP53, EPCAM POLB 2962/4885TSHR 102/4885ALDH1A1 29/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.